United Therapeutics Corporation
NasdaqGS:UTHR
Sector
Location
Market Cap
USD 13.64 B
Share Price
USD 301.50
Avg Daily Volume
599,090
Change (1 day)
0.69%
Change (1 year)
-8.92%
Change (YTD)
-14.55%
United Therapeutics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 1.41 B
United Therapeutics Corporation Operating Cash Flow is USD 1.41 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 44.11% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
United Therapeutics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 979.70 M, a 10.25% change year over year.
-
United Therapeutics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 888.60 M, a 11.48% change year over year.
-
United Therapeutics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 797.10 M, a 26.34% change year over year.
-
United Therapeutics Corporation Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 630.90 M, a -0.71% change year over year.
StockViz
Competitors
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Boston Scientific Corporation
USD 103.14
BSX
+0.18
0.18%
Becton, Dickinson and Company
USD 193.50
BDX
+5.82
3.10%
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sartorius Stedim Biotech S.A.
USD 194.24
DIM.PA
-1.25
-0.64%
bioMérieux S.A.
USD 145.17
BIM.PA
-0.75
-0.51%
Medpace Holdings, Inc.
USD 434.35
MEDP
+5.56
1.30%
Revvity, Inc.
USD 86.84
RVTY
+0.38
0.44%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Exact Sciences Corporation
USD 40.99
EXAS
-2.17
-5.03%
Sysmex Corporation
USD 13.84
6869.T
-0.03
-0.23%
Bio-Techne Corporation
USD 50.42
TECH
+0.27
0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.65
002294.SZ
-0.03
-0.39%
ALK-Abelló A/S
USD 27.79
ALK-B.CO
-1.06
-3.66%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
Thermo Fisher Scientific Inc.
USD 460.72
TMO
+5.98
1.31%
Boston Scientific Corporation
USD 103.14
BSX
+0.18
0.18%
Becton, Dickinson and Company
USD 193.50
BDX
+5.82
3.10%
Fresenius SE & Co. KGaA
USD 50.92
FRE.DE
+1.60
3.26%
Sartorius Stedim Biotech S.A.
USD 194.24
DIM.PA
-1.25
-0.64%
bioMérieux S.A.
USD 145.17
BIM.PA
-0.75
-0.51%
Medpace Holdings, Inc.
USD 434.35
MEDP
+5.56
1.30%
Revvity, Inc.
USD 86.84
RVTY
+0.38
0.44%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.84
603392.SS
-0.02
-0.30%
Exact Sciences Corporation
USD 40.99
EXAS
-2.17
-5.03%
Sysmex Corporation
USD 13.84
6869.T
-0.03
-0.23%
Bio-Techne Corporation
USD 50.42
TECH
+0.27
0.54%
Shenzhen Salubris Pharmaceuticals Co., Ltd.
USD 6.65
002294.SZ
-0.03
-0.39%
ALK-Abelló A/S
USD 27.79
ALK-B.CO
-1.06
-3.66%